BRTX News and Press, BioRestorative Therapies Inc From 02/12/26

2026-02-12 00:55:07 ET Read the full article on Seeking Alpha For further details see: BioRestorative prices $5M stock offering

MELVILLE, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage clinical regenerative medicine innovator focused on stem cell-based therapies and products, today anno...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 8.0% to $1.675 on volume of 808,347,890 shares RenX Enterprises Corp. (RENX) rose 58.7% to $0.2222 on volume of 804,603,182 shares Quince Therapeutics Inc. (QNCX) rose 16.4% to $0....

A look at the top 10 most actives in the United States Quince Therapeutics Inc. (QNCX) rose 305.9% to $0.5277 on volume of 1,593,495,428 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.6% to $1.82 on volume of 450,429,782 shares ProShares UltraShort Silver -2x Shares (ZSL) ...

BioRestorative completed a Type B meeting with the U.S. Food and Drug Administration (“FDA”) regarding a potential accelerated Biologics License Application (“BLA”) approval pathway for the Fast-Track-Designated BRTX-100 program for the treatment of chronic lumbar disc...

A look at the top 10 most actives in the United States Quince Therapeutics Inc. (QNCX) rose 336.9% to $0.567999 on volume of 1,334,472,413 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.4% to $1.835 on volume of 405,466,147 shares Phio Pharmaceuticals Corp. (PHIO) rose 28....

Largest FDA-authorized Phase 2 cell therapy trial conducted in chronic lumbar disc disease The study has enrolled a total of 99 participants, each of whom was randomized to receive either BRTX-100 or placebo Prospective, randomized, double-blind, sham-controlled single-disc study — g...

MELVILLE, N.Y., Nov. 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today anno...

2025-11-13 12:46:55 ET More on BioRestorative Therapies BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript BioRestorative outlines BioCosmeceuticals expansion with new leadership and eyes $63B market opportunity Seeking Alpha’s Quant Rating...

2025-11-12 18:52:26 ET More on BioRestorative Therapies BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on BioRestorative Therapies Historical earnings data for BioRestorative Therapies Financial info...